Retraction Note: Genetic variations in the KIR gene family may contribute to susceptibility to ankylosing spondylitis: a meta-analysis [Mol Biol Rep, (2014), 41, (5311-5319), DOI 10.1007/s11033-014-3402-4];Genetic variations in the KIR gene family may contribute to susceptibility to ankylosing spondylitis: A meta-analysis

Molecular Biology Reports

Volumn 41, Issue 8, 2014, Pages 5311-5319

  Zuo, Hai Ning ^a   Wang, Zhi Long ^a   Cui, Dao Ran ^b   Xin, Da Jiang ^a  

^a Yantai Stomatological Hospital of Yantai   (China)

^b First People's Hospital of Nantong   (China)

Author keywords

Ankylosing spondylitis; Killer cell immunoglobulin like receptor; Meta analysis; Susceptibility

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ANKYLOSING SPONDYLITIS; ARTICLE; GENE; GENE CLUSTER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; KIR GENE; KIR2DL GENE; KIR2DL1 GENE; KIR2DL2 GENE; KIR2DL3 GENE; KIR2DL5 GENE; KIR2DS1 GENE; KIR2DS2 GENE; KIR2DS3 GENE; KIR2DS4 GENE; KIR2DS5 GENE; KIR3DL1 GENE; KIR3DS1 GENE; KIR3DS2 GENE; KIR3DS3 GENE; KIR3DS4 GENE; KIR3DS5 GENE; MULTIGENE FAMILY; PATHOGENESIS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84905083246     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-015-3898-2     Document Type: Erratum

References (25)

1. Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399-405. doi:10.1038/nrrheum.2010.79
2. Chung SD, Chen YK, Liu SP, Lin HC (2013) Association between ed in ankylosing spondylitis: a population-based study. Int J Impot Res 25:229-233. doi:10.1038/ijir.2013.14
3. Dean LE, Jones GT, Macdonald AG, Downham C, Sturrock RD, Macfarlane GJ (2013) Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). doi:10.1093/rheumatology/ket387
4. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379-1390. doi:10.1016/S0140-6736(07)60635-7 (Pubitemid 46590387)
5. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Dilthey A et al (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43:761-767. doi:10.1038/ng.873
6. Diaz-Pena R, Blanco-Gelaz MA, Suarez-Alvarez B, Martinez- Borra J, Lopez-Vazquez A, Alonso-Arias R, Bruges-Armas J, Vidal-Castineira JR et al (2008) Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Hum Immunol 69:437-442. doi:10.1016/j.humimm.2008.04.012
7. Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A (2011) KIR3DL1+HLA-B BW4ILE80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Int J Immunogenet 38:403-409. doi:10.1111/j.1744-313X.2011.01024.x
8. Sivori S, Falco M, Moretta L, Moretta A (2010) Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products. Trends Immunol 31:289-294. doi:10.1016/j.it.2010.05.007
9. Dupont B, Selvakumar A, Steffens U (1997) The killer cell inhibitory receptor genomic region on human chromosome 19q13.4. Tissue Antigens 49:557-563. http://www.ncbi.nlm.nih.gov/pubmed/9234476 (Pubitemid 27267876)
10. McCappin J, Harvey D, Wordsworth BP, Middleton D (2010) No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. Tissue Antigens 75:68-73. doi:10.1111/j.1399-0039.2009.01392.x
11. Campbell KS, Purdy AK (2011) Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132:315-325. doi:10.1111/j.1365-2567.2010. 03398.x
12. Mousavi T, Poormoghim H, Moradi M, Tajik N, Shahsavar F, Asadifar B (2010) Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis. Iran J Immunol 7:88-95
13. Jiao YL, Zhang BC, You L, Li JF, Zhang J, Ma CY, Cui B, Wang LC et al (2010) Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis. J Clin Immunol 30:840-844. doi:10.1007/s10875-010-9444-z
14. Yan H, Wang W, Hu ZD (2012) Association between the subtypes of HLA-B*27 and the polymorphisms of KIR gene. Shanxi Med J 41:281-284
15. Stang A (2010) Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603-605. doi:10.1007/s10654-010-9491-z
16. Zintzaras E, Ioannidis JP (2005) Hegesma: genome search metaanalysis and heterogeneity testing. Bioinformatics 21:3672-3673. doi:10.1093/bioinformatics/ bti536 (Pubitemid 41264106)
17. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in metaanalysis. JAMA 295:676-680. doi:10.1001/jama.295.6.676 (Pubitemid 43209069)
18. Diaz-Pena R, Vidal-Castineira JR, Alonso-Arias R, Suarez-Alvarez B, Vicario JL, Solana R, Collantes E, Lopez-Vazquez A et al (2010) Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum 62:1000-1006. doi:10.1002/art.27332
19. Harvey D, Pointon JJ, Sleator C, Meenagh A, Farrar C, Sun JY, Senitzer D, Middleton D et al (2009) Analysis of killer immu-noglobulin- like receptor genes in ankylosing spondylitis. Ann Rheum Dis 68:595-598. doi:10.1136/ard.2008. 095927
20. Nowak I, Majorczyk E, Wisniewski A, Pawlik A, Magott-Procelewska M, Passowicz-Muszynska E, Malejczyk J, Ploski R et al (2010) Does the KIR2DS5 gene protect from some human diseases? PLoS ONE 5:e12381. doi:10.1371/journal.pone. 0012381
21. Zvyagin IV, Mamedov IZ, Britanova OV, Staroverov DB, Nasonov EL, Bochkova AG, Chkalina AV, Kotlobay AA et al (2010) Contribution of functional KIR3DL1 to ankylosing spondylitis. Cell Mol Immunol 7:471-476. doi:10.1038/cmi.2010.42
22. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J (2010) Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115:1166-1174. doi:10.1182/blood-2009-09- 245746
23. Qin H, Wang Z, Du W, Lee WH, Wu X, Riggs AD, Liu CP (2011) Killer cell ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells. Proc Natl Acad Sci USA 108:2016-2021. doi:10.1073/pnas.1019082108
24. Moon SJ, Oh EJ, Kim Y, Kim KS, Kwok SK, Ju JH, Park KS, Kim HY et al (2013) Diversity of killer cell immunoglobulin-like receptor genes in uveitis associated with autoimmune diseases: ankylosing spondylitis and behcet disease. Ocul Immunol Inflamm 21:135-143. doi:10.3109/09273948.2012.754905
25. Jiao YL, Ma CY, Wang LC, Cui B, Zhang J, You L, Chen ZJ, Li JF et al (2008) Polymorphisms of KIRS gene and HLA-C alleles in patients with ankylosing spondylitis: Possible association with susceptibility to the disease. J Clin Immunol 28:343-349. doi:10.1007/s10875-008-9183-6